Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 16,505 | 16,130 | 15,475 | 14,864 | 13,407 |
| Cost of Goods | 3,667 | 3,944 | 3,754 | 3,643 | 2,865 |
| Gross Profit | 12,837 | 12,187 | 11,722 | 11,220 | 10,543 |
| Operating Expenses | 7,599 | 8,167 | 8,468 | 7,610 | 7,275 |
| Operating Income | 5,905 | 4,963 | 4,007 | 4,254 | 4,132 |
| Other Income | 503 | 335 | 343 | 450 | 105 |
| Pre-tax Income | 6,409 | 5,298 | 4,350 | 4,704 | 4,238 |
| Income Tax | 1,341 | 1,119 | 944 | 1,030 | 810 |
| Net Income Continuous | 5,067 | 4,180 | 3,406 | 3,674 | 3,427 |
| Net Income | $5,067 | $4,180 | $3,406 | $3,674 | $3,427 |
| EPS Basic Total Ops | 0.40 | 0.33 | 0.27 | 0.29 | 0.27 |
| EPS Basic Continuous Ops | 0.40 | 0.33 | 0.27 | 0.29 | 0.27 |
| EPS Diluted Total Ops | 0.40 | 0.33 | 0.27 | 0.29 | 0.27 |
| EPS Diluted Continuous Ops | 0.40 | 0.33 | 0.27 | 0.29 | 0.27 |
| EBITDA(a) | $6,095 | $5,150 | $4,190 | $3,561 | $4,568 |